![Eric Pham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Pham
Private-Equity-Analyst bei
Cowen Investment Management LLC
Profil
Eric Pham is currently the Director at Arch Oncology, Inc. He is also the Managing Director at Avego Healthcare Capital LLC and an Associate at Cowen Investment Management LLC.
Dr. Pham holds a doctorate degree from the University of Houston and an undergraduate degree from the University of California.
Aktive Positionen von Eric Pham
| Unternehmen | Position | Beginn |
|---|---|---|
Cowen Investment Management LLC
 Cowen Investment Management LLC Investment ManagersFinance Cowen Investment Management invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceutical and healthcare services. It provides financing for early and late stage capital requirements. Cowen Investment Management reorganized its healthcare operating segments on December 1, 2023, by combining Cowen Healthcare Investments into a single segment called Blue Owl Healthcare Opportunities Advisors LLC. | Private-Equity-Analyst | - |
Avego Healthcare Capital LLC
 Avego Healthcare Capital LLC Investment ManagersFinance Avego Healthcare invests in private and public companies located in the United States. The firm targets companies operating in the fields of specialty pharmaceuticals, pharma services, life sciences tools, over-the-counter products and medical devices & equipment sectors. It provides financing for buyout stage transactions. | Private Equity Investor | 01.08.2024 |
Ehemalige bekannte Positionen von Eric Pham
| Unternehmen | Position | Ende |
|---|---|---|
Arch Oncology, Inc.
 Arch Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company that develops biologic therapies for treatment of patients with tumors and hematologic malignancies | Direktor/Vorstandsmitglied | - |
Ausbildung von Eric Pham
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Cowen Investment Management LLC
Cowen Investment Management LLC Investment ManagersFinance Cowen Investment Management invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceutical and healthcare services. It provides financing for early and late stage capital requirements. Cowen Investment Management reorganized its healthcare operating segments on December 1, 2023, by combining Cowen Healthcare Investments into a single segment called Blue Owl Healthcare Opportunities Advisors LLC. | Finance |
University of Houston
 University of Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arch Oncology, Inc.
Arch Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company that develops biologic therapies for treatment of patients with tumors and hematologic malignancies | Health Technology |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avego Healthcare Capital LLC
Avego Healthcare Capital LLC Investment ManagersFinance Avego Healthcare invests in private and public companies located in the United States. The firm targets companies operating in the fields of specialty pharmaceuticals, pharma services, life sciences tools, over-the-counter products and medical devices & equipment sectors. It provides financing for buyout stage transactions. | Finance |
